Global

Pharmaceutical Sciences Experts

Mark L. Peterson

Chief Operating Officer & Corporate Secretary
Pharmaceutical
CyCa OncoSolutions
Canada

Biography

Prior to co-founding Cyclenium Pharma, Dr. Peterson was Vice President, IP & Operations at Tranzyme Pharma, where he led the chemistry R & D efforts during the technology development stage of the company and the initiation of its GPCR-based drug discovery programs.  He later focused on building and maintaining an extensive portfolio of over 120 patents and applications protecting Tranzyme's pioneering technology and pharmaceutical product candidates. Previously with Monsanto and Advanced ChemTech, he has worked in a variety of research areas including structure-based design, solid phase organic chemistry, combinatorial libraries, synthetic automation, heterocycles, unnatural amino acids, peptides and peptidomimetics. Dr Peterson received his Ph.D. in Organic Chemistry from Washington State University and conducted post-doctoral research at the University of Minnesota, Department of Medicinal Chemistry.  He is author or co-author of over 85 publications and abstracted presentations plus three book chapters, as well as co-inventor on over 25 patents.   Prior to co-founding Cyclenium Pharma, Dr. Peterson was Vice President, IP & Operations at Tranzyme Pharma, where he led the chemistry R & D efforts during the technology development stage of the company and the initiation of its GPCR-based drug discovery programs.  He later focused on building and maintaining an extensive portfolio of over 120 patents and applications protecting Tranzyme's pioneering technology and pharmaceutical product candidates. Previously with Monsanto and Advanced ChemTech, he has worked in a variety of research areas including structure-based design, solid phase organic chemistry, combinatorial libraries, synthetic automation, heterocycles, unnatural amino acids, peptides and peptidomimetics. Dr Peterson received his Ph.D. in Organic Chemistry from Washington State University and conducted post-doctoral research at the University of Minnesota, Department of Medicinal Chemistry.  He is author or co-author of over 85 publications and abstracted presentations plus three book chapters, as well as co-inventor on over 25 patents.  

Research Interest

 Drug Discovery and Development  Pharmaceutical Technology and Biopharmaceutics Pharmaceutical Analysis

Global Experts from Canada

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America